Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

van der Velden, VHJ; Preijers, F; Johansson, U; Westers, TM; Dunlop, A; Porwit, A; Bene, MC; Valent, P; te Marvelde, J; Wagner-Ballon, O; Oelschlaegel, U; Saft, L; Kordasti, S; Ireland, R; Cremers, E; Alhan, C; Duetz, C; Hobo, W; Chapuis, N; Fontenay, M; Bettelheim, P; Eidenshink-Brodersen, L; Font, P; Loken, MR; Matarraz, S; Ogata, K; Orfao, A; Psarra, K; Subira, D; Wells, DA; Della Porta, MG; Burbury, K; Bellos, F; Weiss, E; Kern, W; van de Loosdrecht, A.

Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet

CYTOMETRY PART B-CLINICAL CYTOMETRY. 2023; 104(1): 15-26 Nº de citas: 31 [doi:10.1002/cyto.b.22046]

Loosdrecht, AA; Kern, W; Porwit, A; Valent, P; Kordasti, S; Cremers, E; Alhan, C; Duetz, C; Dunlop, A; Hobo, W; Preijers, F; Wagner-Ballon, O; Chapuis, N; Fontenay, M; Bettelheim, P; Eidenschink-Brodersen, L; Font, P; Johansson, U; Loken, MR; Marvelde, JG; Matarraz, S; Ogata, K; Oelschlaegel, U; Orfao, A; Psarra, K; Subira, D; Wells, DA; Bene, MC; Della Porta, MG; Burbury, K; Bellos, F; van der Velden, VHJ; Westers, TM; Saft, L; Ireland, R.

Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group

CYTOMETRY PART B-CLINICAL CYTOMETRY. 2023; 104(1): 77-86 Nº de citas: 23 [doi:10.1002/cyto.b.22044]

Izquierdo CP; Mingot-Castellano ME; Fuentes AEK; García-Arroba Peinado J; Cid J; Jimenez MM; Valcarcel D; Gómez-Seguí I; de la Rubia J; Martin P; Goterris R; Hernández L; Tallón I; Varea S; Fernández M; García-Muñoz N; Vara M; Zarzoso MF; García-Candel F; Paciello ML; García-García I; Zalba S; Campuzano V; Gala JM; Estévez JV; Jiménez GM; López Lorenzo JL; Arias EG; Freiría C; Solé M; Ávila Idrovo LF; Hernández Castellet JC; Cruz N; Lavilla E; Pérez-Montaña A; Atucha JA; Moreno Beltrán ME; Moreno Macías JR; Salinas R; Del Rio-Garma J.

Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura

Blood Advances. 2022; 6(24): 6219-6227 Nº de citas: 31 [doi:10.1182/bloodadvances.2022008028]

Villalba, A; Gonzalez-Rodriguez, AP; Arzuaga-Mendez, J; Puig, N; Arnao, M; Arguinano, JM; Jimenez, M; Canet, M; Teruel, AI; Sola, M; Diaz, FJ; Encinas, C; Garcia, A; Rosinol, L; Suarez, A; Gonzalez, MS; Izquierdo, I; Hernandez, MT; Infante, MS; Sanchez, MJ; Sampol, A; de la Rubia, J.

Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM)

LEUKEMIA & LYMPHOMA. 2022; 63(14): 3438-3447 Nº de citas: 8 [doi:10.1080/10428194.2022.2123229]

Buenestado-Serrano S; Recio R; Sola Campoy PJ; Catalán P; Folgueira MD; Villa J; Muñoz Gallego I; de la Cueva VM; Meléndez MA; Andrés Zayas C; Losa-García JE; Goyanes MJ; Fraile Torres A; Von Wermitz A; Fradejas-Villajos I; Del Arco C; Campelo-Gutiérrez C; González Bodi S; López-Wolf D; Iglesias-Franco H; Pérez-Lago L; Arce Arnaez A; Rodriguez Baena E; Ordobas Gavin M; Muñoz P; Delgado R; Cardeñoso L; Viedma E; García de Viedma D.

First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant.

Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2022; 40(10): 546-549 [doi:10.1016/j.eimce.2021.02.013]

Barbui, T; Carobbio, A; Ghirardi, A; Iurlo, A; Sobas, MA; Elli, EM; Rumi, E; De Stefano, V; Lunghi, F; Marchetti, M; Daffini, R; Kabat, MG; Cuevas, B; Fox, ML; Andrade-Campos, MM; Palandri, F; Guglielmelli, P; Benevolo, G; Harrison, C; Foncillas, MA; Bonifacio, M; Alvarez-Larran, A; Kiladjian, JJ; Calderon, EB; Patriarca, A; Cervantes, KQ; Griesshammer, M; Garcia-Gutierrez, V; Sanchez, AM; Mazo, EM; Carli, G; Hernandez-Boluda, JC; Osorio, S; Carreno-Tarragona, G; Serrano, MS; Kusec, R; Elorza, BN; Angona, A; Cirici, BX; Abadia, EL; Koschmieder, S; Cattaneo, D; Bucelli, C; Cichocka, E; de Nalecz, AK; Cavalca, F; Borsani, O; Betti, S; Bellini, M; Curto-Garcia, N; Rambaldi, A; Vannucchi, AM.

Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19

AMERICAN JOURNAL OF HEMATOLOGY. 2022; 97(12): 470-473 Nº de citas: 8 [doi:10.1002/ajh.26732]

Fernandez, CM; Carrasco, NG; Ribelles, AJ; Muniz, NH; Gonzalez, AE; San Simon, AR; Portellano, LC; Medina, SR; Morales, CV.

Results of a survey on the treatment of adolescents and young adult (AYA) sarcoma patients in Spain at present time

CLINICAL & TRANSLATIONAL ONCOLOGY. 2022; 24(12): 2475-2479 [doi:10.1007/s12094-022-02912-w]

Buenestado-Serrano S; Recio R; Sola Campoy PJ; Catalán P; Folgueira MD; Villa J; Muñoz Gallego I; de la Cueva VM; Meléndez MA; Andrés Zayas C; Losa-García JE; Goyanes MJ; Fraile Torres A; Von Wermitz A; Fradejas-Villajos I; Del Arco C; Campelo-Gutiérrez C; González Bodi S; López-Wolf D; Iglesias-Franco H; Pérez-Lago L; Arce Arnaez A; Rodriguez Baena E; Ordobas Gavin M; Muñoz P; Delgado R; Cardeñoso L; Viedma E; García de Viedma D.

First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2022; 40(10): 546-549 Nº de citas: 9 [doi:10.1016/j.eimc.2021.02.006]

Villanueva-Bueno C; Collado-Borrell R; Escudero-Vilaplana V; Revuelta-Herrero JL; Marzal-Alfaro MB; González-Haba E; Arranz-Arija JÁ; Osorio S; Herranz-Alonso A; Sanjurjo-Saez M.

A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital.

Frontiers in Public Health. 2022; 10: 978783-978783 Nº de citas: 3 [doi:10.3389/fpubh.2022.978783]

Errazquin, R; Page, A; Sunol, A; Segrelles, C; Carrasco, E; Peral, J; Garrido-Aranda, A; Del Marro, S; Ortiz, J; Lorz, C; Minguillon, J; Surralles, J; Belendez, C; Alvarez, M; Balmana, J; Bravo, A; Ramirez, A; Garcia-Escudero, R.

Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia

ORAL ONCOLOGY. 2022; 134: Nº de citas: 5 [doi:10.1016/j.oraloncology.2022.106184]

García-Sancho AM; Bellei M; López-Parra M; Gritti G; Cortés M; Novelli S; Panizo C; Petrucci L; Gutiérrez A; Dlouhy I; Bastos-Oreiro M; Sancho JM; Ramírez MJ; Moraleda JM; Carrillo E; Jiménez-Ubieto AI; Jarque I; Orsucci L; García-Torres E; Montalbán C; Dodero A; Arranz R; De Las Heras N; Pascual MJ; López-Jiménez J; Spina M; Re A; De Villambrosia SG; Bobillo S; Federico M; Caballero D.

Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study

HAEMATOLOGICA. 2022; 107(11): 2675-2684 Nº de citas: 21 [doi:10.3324/haematol.2021.279426]

Rey-Bua, B; Cabrero, M; Bento, L; Montoro, J; Bastos-Oreiro, M; Parody, R; Yanez, L; Lopez-Godino, O; Zanabili, J; Herrera, P; Gutierrez, G; Perez, A; Pinana, JL; Novelli, S; Cortes, M; Sureda, AM; Caballero, D; Garcia-Sancho, AM.

Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups

Cancers. 2022; 14(22): [doi:10.3390/cancers14225670]

Baron, F; Labopin, M; Tischer, J; Ciceri, F; Raiola, AM; Blaise, D; Sica, S; Vydra, J; Fanin, R; Diez-Martin, JL; Bulabois, CE; Stolzel, F; Busca, A; Jindra, P; Koc, Y; Chevallier, P; Forcade, E; Rosler, W; Passweg, J; Kulagin, A; Carella, AM; Simand, C; Bazarbachi, A; Pioltelli, P; Nagler, A; Mohty, M.

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia

BONE MARROW TRANSPLANTATION. 2022; 57(11): 1657-1663 Nº de citas: 6 [doi:10.1038/s41409-022-01781-9]

Villapalos-García G; Zubiaur P; Rivas-Durán R; Campos-Norte P; Arévalo-Román C; Fernández-Rico M; García-Fraile Fraile L; Fernández-Campos P; Soria-Chacartegui P; Fernández de Córdoba-Oñate S; Delgado-Wicke P; Fernández-Ruiz E; González-Álvaro I; Sanz J; Abad-Santos F; de Los Santos I.

Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity.

Life Science Alliance. 2022; 5(10): [doi:10.26508/lsa.202201396]

Ruggeri, A; Galimard, JE; Labopin, M; Rafii, H; Blaise, D; Ciceri, F; Diez-Martin, JL; Cornelissen, J; Chevallier, P; Sanchez-Guijo, F; Nicholson, E; Castagna, L; Forcade, E; Kuball, J; Rovira, M; Koc, Y; Pavlu, J; Gulbas, Z; Vydra, J; Baron, F; Sanz, J; Spyridonidis, A; Savani, B; Gluckman, E; Nagler, A; Mohty, M.

Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Transplantation And Cellular Therapy. 2022; 28(10): Nº de citas: 7 [doi:10.1016/j.jtct.2022.07.006]

de Tena, PS; Bailen, R; Oarbeascoa, G; Gomez-Centurion, I; Perez-Corral, A; Carbonell, D; Martinez-Laperche, C; Sancho, M; Bastos-Oreiro, M; Conde-Royo, D; Fernandez-Caldas, P; Munoz, C; Sabell, S; Buno, I; Anguita, J; Diez-Martin, JL; Kwon, M.

Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy

TRANSFUSION. 2022; 62(10): 2143-2147 Nº de citas: 5 [doi:10.1111/trf.17071]

MUÑIZ, P.; ANDRES, C.; CHICANO, M.; CARBONELL, D.; BAILEN, R.; OARBEASCOA, G.; SUAREZ, J.; GOMEZ, I.; DORADO, N.; Gallardo, David; ANGUITA, J.; KWON, M.; MARTINEZ, C.; BUÑO, I..

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation

Frontiers in Immunology. 2022; 13: Nº de citas: 6 [doi:10.3389/fimmu.2022.1002959]

Martinez-Laperche, C; Sanz-Villanueva, L; Crespo, FJD; Muniz, P; Rojas, RM; Carbonell, D; Chicano, M; Suarez-Gonzalez, J; Menarguez, J; Kwon, M; Martin, JLD; Buno, I; Oreiro, MB.

EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment

BMC CANCER. 2022; 22(1): Nº de citas: 10 [doi:10.1186/s12885-022-10070-z]